Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 09:52AM ET
4.27
Dollar change
-0.08
Percentage change
-1.84
%
Index- P/E- EPS (ttm)-111.69 Insider Own26.30% Shs Outstand- Perf Week1.79%
Market Cap7.56M Forward P/E- EPS next Y-6.33 Insider Trans0.00% Shs Float1.30M Perf Month-59.72%
Income-7.03M PEG- EPS next Q-8.14 Inst Own19.56% Short Float2.73% Perf Quarter-85.23%
Sales0.00M P/S- EPS this Y95.52% Inst Trans- Short Ratio0.12 Perf Half Y-85.26%
Book/sh37.84 P/B0.11 EPS next Y78.02% ROA-84.60% Short Interest0.04M Perf Year-93.23%
Cash/sh6.29 P/C0.68 EPS next 5Y- ROE-92.30% 52W Range3.77 - 64.40 Perf YTD-80.56%
Dividend Est.- P/FCF- EPS past 5Y43.05% ROI-62.32% 52W High-93.37% Beta2.38
Dividend TTM- Quick Ratio19.73 Sales past 5Y0.00% Gross Margin- 52W Low13.26% ATR (14)2.08
Dividend Ex-Date- Current Ratio19.73 EPS Y/Y TTM84.81% Oper. Margin0.00% RSI (14)34.05 Volatility10.40% 21.60%
Employees7 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price32.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q96.27% Payout- Rel Volume1.31 Prev Close4.35
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume298.62K Price4.27
SMA20-47.76% SMA50-69.66% SMA200-80.92% Trades Volume40,411 Change-1.84%
Date Action Analyst Rating Change Price Target Change
May-18-17Upgrade Ladenburg Thalmann Neutral → Buy
Dec-16-14Initiated MLV & Co Buy $7
Nov-18-14Initiated WallachBeth Buy $12
Feb-20-24 08:30AM
Feb-08-24 08:53AM
08:16AM
Feb-07-24 08:01PM
Feb-06-24 08:30AM
08:30AM Loading…
Dec-29-23 08:30AM
Nov-17-23 08:30AM
Nov-14-23 05:05AM
Nov-13-23 03:22PM
08:30AM
Aug-28-23 08:20AM
Aug-25-23 07:20AM
Jul-19-23 08:30AM
Jun-23-23 06:24AM
May-31-23 08:54AM
06:44AM Loading…
May-22-23 06:44AM
Apr-21-23 03:59PM
Apr-12-23 02:50PM
08:45AM
Apr-05-23 05:49AM
Mar-22-23 08:45AM
Feb-17-23 07:05AM
Feb-15-23 08:05AM
Feb-07-23 12:10PM
Feb-03-23 08:19AM
Feb-02-23 10:43AM
Feb-01-23 04:31PM
Jan-04-23 08:00AM
Nov-03-22 07:16AM
Oct-10-22 08:30AM
09:29AM Loading…
Sep-15-22 09:29AM
08:30AM
Aug-28-22 09:23AM
Aug-23-22 05:58AM
Jul-01-22 07:52AM
May-25-22 08:30AM
May-23-22 08:30AM
May-19-22 08:18AM
May-18-22 08:30AM
Apr-01-22 09:25AM
Mar-31-22 08:30AM
Mar-30-22 05:00PM
Jan-31-22 04:10PM
Jan-12-22 08:30AM
Jan-05-22 11:48AM
Jan-04-22 08:30AM
Nov-18-21 11:54AM
Nov-16-21 08:30AM
Oct-06-21 08:30AM
Sep-28-21 08:30AM
Sep-20-21 10:43AM
Sep-09-21 08:00AM
Aug-17-21 08:00AM
Aug-12-21 08:00AM
Aug-05-21 08:00AM
Jul-16-21 12:40PM
Jul-07-21 08:00AM
Jun-14-21 04:25PM
Jun-10-21 08:30AM
Jun-07-21 04:52PM
May-17-21 05:15PM
Apr-14-21 07:45AM
Apr-09-21 11:38AM
08:00AM
Apr-07-21 04:45PM
Mar-31-21 04:45PM
Mar-04-21 08:30AM
Mar-02-21 08:15AM
Jan-20-21 10:30AM
07:45AM
Jan-19-21 07:45AM
Dec-29-20 04:29PM
10:12AM
Dec-03-20 07:47AM
Nov-29-20 07:28PM
Nov-16-20 04:45PM
Nov-10-20 08:30AM
Nov-06-20 08:30AM
Oct-15-20 08:30AM
Oct-02-20 08:30AM
Sep-01-20 10:44AM
Aug-31-20 08:30AM
Aug-28-20 10:54AM
Aug-17-20 08:00AM
Jul-20-20 08:45AM
Jul-06-20 07:50PM
Jun-03-20 09:41AM
08:30AM
Jun-02-20 07:30AM
Jun-01-20 05:30AM
May-29-20 01:07PM
Apr-13-20 05:55AM
Apr-09-20 08:30AM
Mar-19-20 10:16AM
Mar-12-20 08:30AM
08:00AM
Feb-21-20 08:30AM
Jan-21-20 06:15AM
Jan-13-20 08:30AM
Dec-20-19 12:03PM
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.